Korean company Medison, best known as a maker of high-quality ultrasound equipment, will soon file for court receivership, according to Asian news services. The company is laboring
Korean company Medison, best known as a maker of high-quality ultrasound equipment, will soon file for court receivership, according to Asian news services. The company is laboring under a huge debt, reported Asia Pulse, and can no longer service its loans. Medison holds 247.2 billion won (US$185.4 million) in interest-bearing debt and has short-term liabilities maturing in 2003 exceeding 175 billion won (US$131.25 million). Company executives contacted creditors Jan. 29 about their decision to file for bankruptcy after missing a 4.4 billion won (US$3.3 million) loan payment, according to the Korea Times.
Founded in 1985, Medison quickly became an international icon for Korean prosperity, capturing a majority of the Korean marketplace for ultrasound and forging deals with international vendors to supply low-cost ultrasound equipment. The company also was a major promoter of real-time 3D ultrasound systems. Its demise appears to be due primarily to ill-considered ventures in Web-based businesses. The plunge in stock prices of companies in which Medison had invested borrowed funds began to destabilize the company more than a year ago, according to Asia Pulse. Medison posted 116 billion won in net losses in 2000 compared with 52.3 billion won in net profits the previous year. In a bid to remain solvent, Medison has been selling assets. Among these was its share in Kretztechnik, which GE purchased in October (SCAN 10/17/01). A statement released by Medison and its creditors, reported by Asia Pulse, said company executives are seeking corporate alliances and foreign investments.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.